ContraFect Stock Price - CFRX

0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ContraFect Corporation CFRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.14 1.29% 10.98 10.4573 11.94 10.90 10.84 00:00:00
Bid Price Ask Price Spread Spread % News
4.00 11.90 7.90 66.39% 5 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,816 367,421 $ 11.22 $ 4,122,669 285,715 0.2693 - 12.10
Last Trade Time Type Quantity Stock Price Currency
16:00:00 3,706 $ 10.98 USD

ContraFect Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 16.83M 1.53M $ -37.68M -5.10 21.70 75.03k
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

ContraFect News

Date Time Source News Article
2/21/202017:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/21/202017:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/21/202017:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/21/202017:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/21/202017:03Edgar (US Regulatory)Current Report Filing (8-k)
2/14/202016:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/14/202016:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)

Latest CFRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CFRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.3512.108.3510.70404,2352.6331.5%
1 Month1.1312.100.723.37677,0029.85871.68%
3 Months0.3612.100.2771.061,932,27510.622,950.0%
6 Months0.385512.100.26930.94613561,035,02310.592,748.25%
1 Year0.463212.100.26930.7560785923,27810.522,270.47%
3 Years2.2512.100.26930.9228377453,3568.73388.0%
5 Years4.1812.100.26931.15295,6266.80162.68%

ContraFect Description

ContraFect Corp is a cinical-stage biotechnology company which focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases including those caused by drug-resistant pathogens, particularly treated in hospital settings. The company has developed advanced lysin product candidate, CF-301 for the treatment of Staph aureus bacteremia, including endocarditis. It also emphasizes on addressing drug-resistant infections using product candidates from its lysin and monoclonal antibody platforms that target conserved regions of either bacteria or viruses. The company operates through a single segment being the Development of therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200222 20:05:51